Recent Advances in Treatment of Systemic Sclerosis and Morphea
Authors:
- 12 December 2023
- journal article
- review article
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 25 (2) , 213-226
Abstract
Systemic sclerosis (SSc) and morphea are autoimmune sclerosing diseases that cause significant morbidity, and in the case of SSc, mortality. The pathogenesis of both SSc and morphea share vascular dysfunction, auto-reactive T cells and Th2-associated cytokines, such as interleukin 4, and overproduction of transforming growth factor beta (TGFβ). TGFβ stimulates fibroblast collagen and extra-cellular matrix production. Although morphea and SSc have similar pathogenic pathways and histological findings, they are distinct diseases. Recent advances in treatment of morphea, skin sclerosis in SSc, and interstitial lung disease in SSc are focused on targeting known pathogenic pathways.Keywords
This publication has 133 references indexed in Scilit:
- Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced sclerodermaClinical and Experimental Immunology, 2010
- Imatinib treatment of generalized localized scleroderma (morphea)Journal of the American Academy of Dermatology, 2010
- Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept studyRheumatology, 2009
- Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective studyBritish Journal of Dermatology, 2009
- Neurologic manifestations of localized sclerodermaNeurology, 2008
- Photochemotherapy for localized morphoea: effect on clinical and molecular markersClinical and Experimental Dermatology, 2008
- UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-VBritish Journal of Dermatology, 2008
- Period of remission after treatment with UVA‐1 in sclerodermic skin diseasesJournal of the European Academy of Dermatology and Venereology, 2008
- Ocular involvement in children with localised scleroderma: a multi-centre studyBritish Journal of Ophthalmology, 2007
- A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized sclerodermaJournal of the American Academy of Dermatology, 2006